$CSBR
CHAMPIONS ONCOLOGY, INC.

2021 Q4 Form 10-Q Financial Statement

#000162828021024951 Filed on December 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4
Revenue $11.79M $10.12M
YoY Change 16.5% 32.68%
Cost Of Revenue $5.609M $5.644M
YoY Change -0.62% 45.43%
Gross Profit $6.177M $4.473M
YoY Change 38.1% 19.47%
Gross Profit Margin 52.41% 44.21%
Selling, General & Admin $3.615M $2.816M
YoY Change 28.37% 33.33%
% of Gross Profit 58.52% 62.96%
Research & Development $2.299M $1.650M
YoY Change 39.33% 23.04%
% of Gross Profit 37.22% 36.89%
Depreciation & Amortization $346.0K $254.0K
YoY Change 36.22% 56.79%
% of Gross Profit 5.6% 5.68%
Operating Expenses $5.914M $4.466M
YoY Change 32.42% -39.11%
Operating Profit $263.0K $7.000K
YoY Change 3657.14% -97.59%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $26.00K $9.000K
YoY Change 188.89% -66.67%
Pretax Income $289.0K $16.00K
YoY Change 1706.25% -94.97%
Income Tax $12.00K $15.00K
% Of Pretax Income 4.15% 93.75%
Net Earnings $277.0K $1.000K
YoY Change 27600.0% -99.67%
Net Earnings / Revenue 2.35% 0.01%
Basic Earnings Per Share $0.02 $0.00
Diluted Earnings Per Share $0.02 $0.00
COMMON SHARES
Basic Shares Outstanding 13.43M shares 13.06M shares
Diluted Shares Outstanding 14.55M shares 15.06M shares

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.781M $8.550M
YoY Change -44.08% 207.55%
Cash & Equivalents $4.800M $8.600M
Short-Term Investments
Other Short-Term Assets $731.0K $480.0K
YoY Change 52.29% 33.33%
Inventory
Prepaid Expenses
Receivables $8.190M $5.960M
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.70M $14.99M
YoY Change -8.59% 112.17%
LONG-TERM ASSETS
Property, Plant & Equipment $6.983M $4.872M
YoY Change 43.33% 58.13%
Goodwill $335.0K $335.0K
YoY Change 0.0% -49.93%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $15.00K $36.00K
YoY Change -58.33% -71.88%
Total Long-Term Assets $15.59M $10.77M
YoY Change 44.79% 56.5%
TOTAL ASSETS
Total Short-Term Assets $13.70M $14.99M
Total Long-Term Assets $15.59M $10.77M
Total Assets $29.30M $25.76M
YoY Change 13.73% 84.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.477M $3.948M
YoY Change -11.93% 41.66%
Accrued Expenses $1.911M $1.995M
YoY Change -4.21% 137.22%
Deferred Revenue $6.132M $6.188M
YoY Change -0.9% 49.25%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $20.00K
YoY Change
Total Short-Term Liabilities $12.47M $12.75M
YoY Change -2.27% 54.54%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $235.0K $181.0K
YoY Change 29.83% 19.87%
Total Long-Term Liabilities $235.0K $181.0K
YoY Change 29.83% 19.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.47M $12.75M
Total Long-Term Liabilities $235.0K $181.0K
Total Liabilities $21.23M $18.87M
YoY Change 12.5% 59.44%
SHAREHOLDERS EQUITY
Retained Earnings -$72.40M -$72.60M
YoY Change -0.28% 2.25%
Common Stock $80.50M $79.49M
YoY Change 1.27% 8.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.071M $6.893M
YoY Change
Total Liabilities & Shareholders Equity $29.30M $25.76M
YoY Change 13.73% 84.7%

Cashflow Statement

Concept 2021 Q4 2020 Q4
OPERATING ACTIVITIES
Net Income $277.0K $1.000K
YoY Change 27600.0% -99.67%
Depreciation, Depletion And Amortization $346.0K $254.0K
YoY Change 36.22% 56.79%
Cash From Operating Activities $1.228M $880.0K
YoY Change 39.55% 144.44%
INVESTING ACTIVITIES
Capital Expenditures -$566.0K -$500.0K
YoY Change 13.2% -317.39%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities -$566.0K -$500.0K
YoY Change 13.2% -317.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 121.0K 1.240M
YoY Change -90.24%
NET CHANGE
Cash From Operating Activities 1.228M 880.0K
Cash From Investing Activities -566.0K -500.0K
Cash From Financing Activities 121.0K 1.240M
Net Change In Cash 783.0K 1.620M
YoY Change -51.67% 350.0%
FREE CASH FLOW
Cash From Operating Activities $1.228M $880.0K
Capital Expenditures -$566.0K -$500.0K
Free Cash Flow $1.794M $1.380M
YoY Change 30.0% 961.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000771856
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2021Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020Q4 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2020Q4 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q4 us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
us-gaap Type Of Cost Good Or Service Extensible List
TypeOfCostGoodOrServiceExtensibleList
http://fasb.org/us-gaap/2021-01-31#ServiceMember
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P0Y
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-11504
dei Entity Registrant Name
EntityRegistrantName
CHAMPIONS ONCOLOGY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1401755
dei Entity Address Address Line1
EntityAddressAddressLine1
One University Plaza, Suite 307
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07601
dei Entity Address City Or Town
EntityAddressCityOrTown
Hackensack
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei City Area Code
CityAreaCode
201
dei Local Phone Number
LocalPhoneNumber
808-8400
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
CSBR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13514894 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4781000 USD
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4687000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8190000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6986000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
731000 USD
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
957000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
13702000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
12630000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8261000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8521000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6983000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6090000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
15000 USD
CY2021Q4 us-gaap Goodwill
Goodwill
335000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
335000 USD
CY2021Q4 us-gaap Assets
Assets
29296000 USD
CY2021Q2 us-gaap Assets
Assets
27591000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3477000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1894000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1911000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2231000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
930000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
818000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15000 USD
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
0 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6132000 USD
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6256000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12465000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
11199000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8525000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8783000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
235000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
181000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
21225000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
20163000 USD
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13496144 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13496144 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13414066 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13414066 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
14000 USD
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
13000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
80482000 USD
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79945000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72425000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72530000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8071000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7428000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29296000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
27591000 USD
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11786000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10117000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23039000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19664000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5609000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5644000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11005000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
10980000 USD
CY2021Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2299000 USD
CY2020Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1650000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4603000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3247000 USD
CY2021Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1640000 USD
CY2020Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1348000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3214000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2556000 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1975000 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1468000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4129000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2850000 USD
CY2021Q4 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
11523000 USD
CY2020Q4 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
10110000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
22951000 USD
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
19633000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
263000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
7000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
88000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
31000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
26000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
43000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
73000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
289000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
131000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
104000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
277000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1000 USD
us-gaap Net Income Loss
NetIncomeLoss
105000 USD
us-gaap Net Income Loss
NetIncomeLoss
76000 USD
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13428508 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13064191 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13145930 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12811921 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14549136 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15062103 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14213450 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14563060 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
7428000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
280000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
2000 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-172000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
7538000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
134000 USD
CY2021Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
122000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
277000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
8071000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
5318000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
120000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
75000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
5513000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000 USD
CY2020Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
1294000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6893000 USD
us-gaap Net Income Loss
NetIncomeLoss
105000 USD
us-gaap Net Income Loss
NetIncomeLoss
76000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
414000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
205000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
663000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
584000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
4000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0 USD
us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
75000 USD
csbr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
519000 USD
csbr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
79000 USD
csbr Reversal Of Provision For Doubtful Accounts
ReversalOfProvisionForDoubtfulAccounts
117000 USD
csbr Reversal Of Provision For Doubtful Accounts
ReversalOfProvisionForDoubtfulAccounts
49000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1321000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1237000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-226000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
92000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1506000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
568000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-320000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-507000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
15000 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
54000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3000 USD
csbr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
406000 USD
csbr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-138000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-124000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
373000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1444000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
164000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1473000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1224000 USD
csbr Proceeds From Refund Of Security Deposit
ProceedsFromRefundOfSecurityDeposit
0 USD
csbr Proceeds From Refund Of Security Deposit
ProceedsFromRefundOfSecurityDeposit
92000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1473000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1132000 USD
csbr Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
123000 USD
csbr Proceeds From Exercise Of Options And Warrants
ProceedsFromExerciseOfOptionsAndWarrants
1294000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
115000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
123000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1179000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
94000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
211000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4687000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8342000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4781000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8553000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
205000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3872000 USD
csbr Receipt Of No Cost Equipment
ReceiptOfNoCostEquipment
79000 USD
csbr Receipt Of No Cost Equipment
ReceiptOfNoCostEquipment
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
240000 USD
csbr Number Of Operating Subsidiaries
NumberOfOperatingSubsidiaries
3 subsidiary
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
CY2021Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 USD
us-gaap Net Income Loss
NetIncomeLoss
105000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1400000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72400000 USD
CY2021Q4 csbr Working Capital Deficit
WorkingCapitalDeficit
1200000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4800000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
277000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1000 USD
us-gaap Net Income Loss
NetIncomeLoss
105000 USD
us-gaap Net Income Loss
NetIncomeLoss
76000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13428508 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13064191 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13145930 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12811921 shares
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
277000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
1000 USD
us-gaap Net Income Loss
NetIncomeLoss
105000 USD
us-gaap Net Income Loss
NetIncomeLoss
76000 USD
CY2021Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
277000 USD
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
105000 USD
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
76000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13428508 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13064191 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13145930 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12811921 shares
CY2021Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1120628 shares
CY2020Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1997912 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1067520 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1751139 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14549136 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15062103 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14213450 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14563060 shares
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1634928 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1651478 shares
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
181000 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
181000 USD
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
3000 USD
CY2021Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
3000 USD
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2020Q4 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0 USD
CY2021Q4 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
0 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28000 USD
CY2021Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4654000 USD
CY2021Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4304000 USD
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3991000 USD
CY2021Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
3020000 USD
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8645000 USD
CY2021Q2 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
7324000 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
455000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
338000 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8190000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6986000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6132000 USD
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
6256000 USD
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
The majority of the Company's revenue arrangements are service contracts that are complete within a year or less. There are a few contracts that range in duration between 1 and 3 years.
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11786000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10117000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
23039000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19664000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
11595000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
10046000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
4612000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
3956000 USD
CY2021Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
6983000 USD
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
6090000 USD
CY2021Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
346000 USD
CY2020Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
254000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
663000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
478000 USD
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
343000 USD
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
343000 USD
CY2021Q4 csbr Finance Lease Depreciation And Amortization Expenses
FinanceLeaseDepreciationAndAmortizationExpenses
0 USD
CY2020Q4 csbr Finance Lease Depreciation And Amortization Expenses
FinanceLeaseDepreciationAndAmortizationExpenses
53000 USD
csbr Finance Lease Depreciation And Amortization Expenses
FinanceLeaseDepreciationAndAmortizationExpenses
0 USD
csbr Finance Lease Depreciation And Amortization Expenses
FinanceLeaseDepreciationAndAmortizationExpenses
106000 USD
CY2020Q4 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
40000 USD
CY2021Q4 us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
40000 USD
us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
81000 USD
us-gaap Hosting Arrangement Service Contract Implementation Cost Expense Amortization
HostingArrangementServiceContractImplementationCostExpenseAmortization
81000 USD
CY2021Q4 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization
1400000 USD
CY2021Q2 us-gaap Hosting Arrangement Service Contract Implementation Cost Capitalized Accumulated Amortization
HostingArrangementServiceContractImplementationCostCapitalizedAccumulatedAmortization
991000 USD
csbr Finance Lease Cost
FinanceLeaseCost
149000 USD
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2018Q3 csbr Finance Lease Cost
FinanceLeaseCost
266000 USD
CY2019Q4 csbr Finance Lease Number Of Right Of Use Assets Acquired
FinanceLeaseNumberOfRightOfUseAssetsAcquired
2 asset
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2020 csbr Finance Lease Cost
FinanceLeaseCost
231000 USD
CY2021Q4 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
CY2020Q4 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
53000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
0 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
106000 USD
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
0 USD
CY2021Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134000 USD
CY2020Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
85000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
414000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
205000 USD
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0082
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0039
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7283
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.6594
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.6621
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7264
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7283
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.05
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.29
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.33
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1653646 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.96
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y5M1D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11384000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
85532 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.01
csbr Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm
P9Y7M24D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
82078 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.91
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
12500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.74
csbr Share Based Compensation Arrangement By Share Based Payment Award Options Canceled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCanceledInPeriod
4672 shares
csbr Share Based Compensation Arrangements By Share Based Payment Award Options Canceled In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsCanceledInPeriodWeightedAverageExercisePrice
3.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
5000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.60
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1634928 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.29
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M7D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
9246000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1634928 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.29
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M7D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
9246000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1300678 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.69
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M3D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
8189000 USD
CY2021Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
467000 USD
CY2020Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
314000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
932000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
629000 USD
CY2020Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P6M
CY2020Q1 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P6M
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8261000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8521000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
930000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
818000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8525000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8783000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y2M23D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0576
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1307000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2630000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2694000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2731000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2775000 USD
CY2021Q4 csbr Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
7947000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
20084000 USD
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
4600 USD
us-gaap Royalty Expense
RoyaltyExpense
194000 USD
CY2021 us-gaap Royalty Expense
RoyaltyExpense
127000 USD
CY2021Q4 us-gaap Royalty Expense
RoyaltyExpense
50000 USD
CY2020Q4 us-gaap Royalty Expense
RoyaltyExpense
12000 USD

Files In Submission

Name View Source Status
0001628280-21-024951-index-headers.html Edgar Link pending
0001628280-21-024951-index.html Edgar Link pending
0001628280-21-024951.txt Edgar Link pending
0001628280-21-024951-xbrl.zip Edgar Link pending
csbr-20211031.htm Edgar Link pending
csbr-20211031.xsd Edgar Link pending
csbr-20211031_cal.xml Edgar Link unprocessable
csbr-20211031_def.xml Edgar Link unprocessable
csbr-20211031_htm.xml Edgar Link completed
csbr-20211031_lab.xml Edgar Link unprocessable
csbr-20211031_pre.xml Edgar Link unprocessable
csbrq21031202110-qex311.htm Edgar Link pending
csbrq21031202110-qex312.htm Edgar Link pending
csbrq21031202110-qex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending